Fred Relaix

Professor Fred Relaix leads a prominent research group at the Faculty of Health, University of Paris-Est Créteil, with dual appointments at INSERM's Institut Mondor de Recherche Biomédicale and strong affiliations with ENVA, EFS, and APHP. His lab operates under AFM-Telethon's Strategic Pole Translamuscle funding and actively participates in national consortia including Labex-Revive and GDR Stem cells in vivo, positioning it at the nexus of basic muscle biology and clinical translation.

Research centers on skeletal muscle as a model system for understanding development, regeneration, and pathology. Key pillars include:

• Transcriptional/epigenetic networks governing satellite cell quiescence, activation, and self-renewal
• Stem cell-niche interactions involving perivascular cells, macrophages, and extracellular matrix components
• Pathogenesis mechanisms and therapeutic development for Duchenne Muscular Dystrophy
• Creation of accurate preclinical models for therapeutic validation

The lab's publication trajectory (2021-2025) reveals intensifying focus on neurovascular-stem cell axes (Angpt1, sympathetic innervation), metabolic influences on regeneration (obesity, cardiolipin), and cardiomyopathy mechanisms in dystrophy. Recent work emphasizes translational applications including hormone-based therapies (TSH receptor) and identifying regeneration barriers (cellular senescence).

Funding and recognition highlights:

• Core support from AFM-Telethon's Strategic Pole Translamuscle
• Active roles in Labex-Revive and GDR Stem cells in vivo consortia
• Publications in high-impact journals including Developmental Cell, Science Translational Medicine, and Nature Communications

Professor Relaix mentors students within a hospital-adjacent research ecosystem at Mondor Hospital, enabling direct clinical correlation. Current projects investigate genome-editing therapeutic schemes, neurovascular signaling restoration, and metabolic interventions for muscle disorders. The lab maintains strategic partnerships with veterinary (ENVA) and blood research (EFS) institutions for comparative and translational insights.

The Relaix Lab represents a powerhouse in European muscle research, uniquely positioned to translate fundamental stem cell discoveries into therapies for debilitating neuromuscular conditions through its integrated academic-clinical consortium framework.